Cargando…

Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic

BACKGROUND: The aim of this study was to identify mutations of rpoB, katG, inhA and ahp-genes associated Mycobacterium tuberculosis resistance to rifampicin (RIF) and isoniazid (INH) in Kyrgyz Republic. We studied 633 smear samples from the primary pulmonary tuberculosis (TB) patients. We verified M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isakova, Jainagul, Sovkhozova, Nurmira, Vinnikov, Denis, Goncharova, Zoy, Talaibekova, Elnura, Aldasheva, Nazira, Aldashev, Almaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863813/ https://www.ncbi.nlm.nih.gov/pubmed/29566660 http://dx.doi.org/10.1186/s12866-018-1168-x

Ejemplares similares

The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females
por: Isakova, Jainagul, et al.
Publicado: (2017)

The association of Val109Asp polymorphic marker of intelectin 1 gene with abdominal obesity in Kyrgyz population
por: Isakova, Jainagul, et al.
Publicado: (2018)

ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
por: Isakova, Jainagul, et al.
Publicado: (2019)

ADIPOQ,KCNJ11 and TCF7L2 polymorphisms in type 2 diabetes in Kyrgyz population: A case‐control study
por: Isakova, Jainagul, et al.
Publicado: (2018)

In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA
por: Ferreira, Sergio Luiz Montego, et al.
Publicado: (2014)

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
por: Charan, Ashok Singh, et al.
Publicado: (2020)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates among Ethiopian TB Patients: A Systematic Review
por: Seid, Aynias, et al.
Publicado: (2022)

The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China
por: Liu, Liguo, et al.
Publicado: (2018)

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America
por: Dalla Costa, Elis R, et al.
Publicado: (2009)

Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks
por: Mizuno, Shiro, et al.
Publicado: (2015)

Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis
por: Ranjan, K. P., et al.
Publicado: (2023)

Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhA
por: Zhang, Qianqian, et al.
Publicado: (2022)

Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
por: Xia, Yi, et al.
Publicado: (2018)

Correction to Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
por: Flint, Lindsay, et al.
Publicado: (2020)

Predictive Power of ETRE Polymorphism and Katg463 Mutation to INH-Resistance of M.tuberculosis
por: WEN, Yu-feng, et al.
Publicado: (2015)

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations
por: Wasserman, Sean, et al.
Publicado: (2020)

In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
por: Sulistyowaty, Melanny Ika, et al.
Publicado: (2023)

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
por: Cohen, Elisangela ML, et al.
Publicado: (2011)

Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA
por: Kumar, Vivek, et al.
Publicado: (2015)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
por: Martínez-Hoyos, María, et al.
Publicado: (2016)

Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA
por: Prati, Federica, et al.
Publicado: (2018)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis
por: Harrison, Gregory A., et al.
Publicado: (2023)

Bacillus anthracis Protease InhA Increases Blood-Brain Barrier Permeability and Contributes to Cerebral Hemorrhages
por: Mukherjee, Dhritiman V., et al.
Publicado: (2011)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
por: Abkar, Roya, et al.
Publicado: (2016)

An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features
por: De Paris, Renata, et al.
Publicado: (2015)

Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
por: Venugopala, Katharigatta N., et al.
Publicado: (2021)

A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA
por: Li, Huei-Jiun, et al.
Publicado: (2014)

Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations
por: Merget, Benjamin, et al.
Publicado: (2015)

A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model
por: De Paris, Renata, et al.
Publicado: (2018)

InhA1-Mediated Cleavage of the Metalloprotease NprA Allows Bacillus cereus to Escape From Macrophages
por: Haydar, Abbass, et al.
Publicado: (2018)

InhA, the enoyl-thioester reductase from Mycobacterium tuberculosis forms a covalent adduct during catalysis
por: Vögeli, Bastian, et al.
Publicado: (2018)

In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
por: Pinzi, Luca, et al.
Publicado: (2019)

In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors
por: Ibrahim, Tarek S., et al.
Publicado: (2020)

Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide–Hydrazone and Thiadiazole Derivatives Targeting InhA
por: Teneva, Yoanna, et al.
Publicado: (2023)

Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods
por: Takawira, Faustinos Tatenda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7igih8lo7188a5uo10dhu5ad0r